Evaluation the Safety and Efficacy of Cilostazol in Treatment of Patients With Fatty Liver Disease
Condition:   Fatty Liver, Nonalcoholic Interventions:   Drug: Cilostazol 50 MG;   Drug: Placebo Sponsor:   Sadat City University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2021 Category: Research Source Type: clinical trials

Retina is a Marker for Cerebrovascular Heath
Conditions:   Cerebral Small Vessel Diseases;   Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy;   Cerebral Microbleeding;   Sporadic White Matter Disease Intervention:   Drug: Cilostazol Sponsor:   Mayo Clinic Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2021 Category: Research Source Type: clinical trials